These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18373313)

  • 1. High-intensity hemodialysis: the wave of the future?
    Ing TS; Ronco C; Blagg CR
    Int J Artif Organs; 2008 Mar; 31(3):201-12. PubMed ID: 18373313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of combination therapy with peritoneal dialysis and hemodialysis on left ventricular hypertrophy.
    Tanaka M; Mise N; Nakajima H; Uchida L; Ishimoto Y; Kotera N; Tanaka S; Kurita N; Sugimoto T
    Perit Dial Int; 2011; 31(5):598-600. PubMed ID: 21976476
    [No Abstract]   [Full Text] [Related]  

  • 3. The prevalence of left ventricular hypertrophy in Chinese hemodialysis patients is higher than that in peritoneal dialysis patients.
    Tian JP; Wang T; Wang H; Cheng LT; Tian XK; Lindholm B; Axelsson J; Du FH
    Ren Fail; 2008; 30(4):391-400. PubMed ID: 18569912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Volume control and left ventricular hypertrophy in patients with end-stage renal disease.
    De Francisco AL; Piñera C
    Int J Artif Organs; 2004 Feb; 27(2):83-7. PubMed ID: 15061470
    [No Abstract]   [Full Text] [Related]  

  • 5. A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients.
    Wang AY; Wang M; Woo J; Law MC; Chow KM; Li PK; Lui SF; Sanderson JE
    Kidney Int; 2002 Aug; 62(2):639-47. PubMed ID: 12110029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of dialysis modality on the appropriateness of left ventricular mass in patients with end-stage renal disease.
    Paneni F; Gregori M; Ciavarella GM; Sciarretta S; Tocci G; Palano F; Domenici A; Punzo G; De Biase L; Menè P; Volpe M
    Int J Cardiol; 2011 Jun; 149(2):250-252. PubMed ID: 21392833
    [No Abstract]   [Full Text] [Related]  

  • 7. Left ventricular hypertrophy is associated with arterial stiffness and vascular calcification in hemodialysis patients.
    Nitta K; Akiba T; Uchida K; Otsubo S; Otsubo Y; Takei T; Ogawa T; Yumura W; Kabaya T; Nihei H
    Hypertens Res; 2004 Jan; 27(1):47-52. PubMed ID: 15055255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular mass in chronic kidney disease and ESRD.
    Glassock RJ; Pecoits-Filho R; Barberato SH
    Clin J Am Soc Nephrol; 2009 Dec; 4 Suppl 1():S79-91. PubMed ID: 19996010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An association between inflammatory state and left ventricular hypertrophy in hemodialysis patients.
    Erten Y; Tulmac M; Derici U; Pasaoglu H; Altok Reis K; Bali M; Arinsoy T; Cengel A; Sindel S
    Ren Fail; 2005; 27(5):581-9. PubMed ID: 16152997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive Hemodialysis, Left Ventricular Hypertrophy, and Cardiovascular Disease.
    McCullough PA; Chan CT; Weinhandl ED; Burkart JM; Bakris GL
    Am J Kidney Dis; 2016 Nov; 68(5S1):S5-S14. PubMed ID: 27772643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal dialysis is not a superior therapy to hemodialysis: a comparison.
    Stokes JB
    Blood Purif; 2012; 33(1-3):160-4. PubMed ID: 22269603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for left ventricular hypertrophy in chronic hemodialysis patients.
    Washio M; Okuda S; Mizoue T; Kiyama S; Ando T; Sanai T; Hirakata H; Nanishi F; Kiyohara C; Ogimoto I; Yoshimura T; Fujishima M
    Clin Nephrol; 1997 Jun; 47(6):362-6. PubMed ID: 9202865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances and innovations in dialysis in the 21st century.
    Power A; Duncan N; Goodlad C
    Postgrad Med J; 2009 Feb; 85(1000):102-7. PubMed ID: 19329705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modality selection.
    Diaz-Buxo JA
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S112-7. PubMed ID: 11443757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of the serum levels of serum troponins I and T, albumin and C-Reactive protein in chronic hemodialysis patients and their relationship with left ventricular hypertrophy and heart failure.
    Forghani MS; Jadidoleslami MS; Naleini SN; Rajabnia M
    Diabetes Metab Syndr; 2019; 13(1):522-525. PubMed ID: 30641758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of an arteriovenous access for hemodialysis to left ventricular hypertrophy.
    Ori Y; Korzets A; Katz M; Erman A; Weinstein T; Malachi T; Gafter U
    Am J Kidney Dis; 2002 Oct; 40(4):745-52. PubMed ID: 12324909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dialysis therapy and renal transplantation].
    Riegel W; Schnülle P
    Dtsch Med Wochenschr; 2011 Oct; 136(40):2025-8. PubMed ID: 21960332
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative mortality of hemodialysis and peritoneal dialysis in Canada.
    Murphy SW; Foley RN; Barrett BJ; Kent GM; Morgan J; Barré P; Campbell P; Fine A; Goldstein MB; Handa SP; Jindal KK; Levin A; Mandin H; Muirhead N; Richardson RM; Parfrey PS
    Kidney Int; 2000 Apr; 57(4):1720-6. PubMed ID: 10760108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Substitutes for renal function. Technical trends and logistics of treatment].
    Legrain M; Rottembourg J
    C R Seances Soc Biol Fil; 1981; 175(5):669-93. PubMed ID: 6456794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Echocardiographic abnormalities in chronic hemodialysis patients: prevalence and risk factors].
    Ezziani M; Najdi A; Mikou S; Elhassani A; Akrichi MA; Hanin H; Arrayhani M; Houssaini TS
    Pan Afr Med J; 2014; 18():216. PubMed ID: 25419342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.